Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP774715.RAsrZ_iFlGO6iO-Yuxt07H2zG7FoYwyiGx1bpnzxeHIl4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP774715.RAsrZ_iFlGO6iO-Yuxt07H2zG7FoYwyiGx1bpnzxeHIl4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP774715.RAsrZ_iFlGO6iO-Yuxt07H2zG7FoYwyiGx1bpnzxeHIl4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP774715.RAsrZ_iFlGO6iO-Yuxt07H2zG7FoYwyiGx1bpnzxeHIl4130_provenance.
- NP774715.RAsrZ_iFlGO6iO-Yuxt07H2zG7FoYwyiGx1bpnzxeHIl4130_assertion description "[We previously showed that the antiangiogenic compound TNP-470, an irreversible methionine aminopeptidase 2 (MetAP2) inhibitor, suppressed local and disseminated human neuroblastoma growth rates in murine models but had significant associated toxicity at the effective dose.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP774715.RAsrZ_iFlGO6iO-Yuxt07H2zG7FoYwyiGx1bpnzxeHIl4130_provenance.
- NP774715.RAsrZ_iFlGO6iO-Yuxt07H2zG7FoYwyiGx1bpnzxeHIl4130_assertion evidence source_evidence_literature NP774715.RAsrZ_iFlGO6iO-Yuxt07H2zG7FoYwyiGx1bpnzxeHIl4130_provenance.
- NP774715.RAsrZ_iFlGO6iO-Yuxt07H2zG7FoYwyiGx1bpnzxeHIl4130_assertion SIO_000772 15814649 NP774715.RAsrZ_iFlGO6iO-Yuxt07H2zG7FoYwyiGx1bpnzxeHIl4130_provenance.
- NP774715.RAsrZ_iFlGO6iO-Yuxt07H2zG7FoYwyiGx1bpnzxeHIl4130_assertion wasDerivedFrom befree-20140225 NP774715.RAsrZ_iFlGO6iO-Yuxt07H2zG7FoYwyiGx1bpnzxeHIl4130_provenance.
- NP774715.RAsrZ_iFlGO6iO-Yuxt07H2zG7FoYwyiGx1bpnzxeHIl4130_assertion wasGeneratedBy ECO_0000203 NP774715.RAsrZ_iFlGO6iO-Yuxt07H2zG7FoYwyiGx1bpnzxeHIl4130_provenance.
- befree-20140225 importedOn "2014-02-25" NP774715.RAsrZ_iFlGO6iO-Yuxt07H2zG7FoYwyiGx1bpnzxeHIl4130_provenance.